Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07547683 · ClinicalTrials.gov registry record · NA
Usability of the Regen Gait Therapy Robot in Healthy Adults
A NA study, sponsored by University of Texas at Austin.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT07547683: Recruiting NA study, sponsored by University of Texas at Austin.
NCT07547683 is a NA study that is actively recruiting participants, run by University of Texas at Austin. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07547683, a NA study, is actively recruiting participants, sponsored by University of Texas at Austin.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
Regen is a robot-assisted device designed to help therapists and improve the quality of treatment. It works by replicating the movement of the therapist and providing assistance as needed for the patient. This study aims to assess the safety, feasibility, usability, and ability to Regen to replicate the movement pattern of therapist in young healthy adults during treadmill walking.
Primary Outcome
The System Usability Scale (SUS) will be used to assess the usability of the device. The SUS consists of 10 items scored on a 5-point Likert scale and converted to a total score ranging from 0 to 100, with higher scores indicating better usability.
Interventions
- DEVICE Regen Rehabilitation Assistive Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2026-03-26 |
| Est. Completion | 2026-06-01 |
| Phase | NA |
What NCT07547683 shows while recruiting
NCT07547683 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Regen Rehabilitation Assistive Device is the first listed.
NCT07547683 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07547683 about?
NCT07547683 is a clinical study titled "Usability of the Regen Gait Therapy Robot in Healthy Adults". Regen is a robot-assisted device designed to help therapists and improve the quality of treatment. It works by replicating the movement of the therapist and providing assistance as needed for the patient. This study aims to assess the safety, feasibility, usability, and ability to Regen to replicate...
What is the current status of trial NCT07547683?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2026-03-26. Estimated completion is 2026-06-01.
What interventions are being tested in trial NCT07547683?
The interventions under investigation include: Regen Rehabilitation Assistive Device (DEVICE).
Who is sponsoring clinical trial NCT07547683?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07547683's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI